ANKERS LÆKAGESØGNING ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.2% 7.4% 11.1% 15.6% 15.4%  
Credit score (0-100)  39 32 20 11 12  
Credit rating  BBB BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  778 686 283 24.0 23.6  
EBITDA  255 114 -59.5 -42.1 -34.4  
EBIT  250 87.3 -90.7 -73.3 -65.4  
Pre-tax profit (PTP)  278.8 86.4 -92.9 -73.6 -66.1  
Net earnings  215.1 67.5 -84.4 -73.3 -66.1  
Pre-tax profit without non-rec. items  279 86.4 -92.9 -73.6 -66.1  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  111 124 92.7 61.5 30.6  
Shareholders equity total  463 420 223 150 83.6  
Interest-bearing liabilities  0.0 0.3 0.7 0.4 0.4  
Balance sheet total (assets)  716 672 276 180 133  

Net Debt  -464 -320 -132 -79.7 -83.8  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  778 686 283 24.0 23.6  
Gross profit growth  -15.4% -11.9% -58.7% -91.5% -1.4%  
Employees  2 2 2 0 1  
Employee growth %  0.0% 0.0% 0.0% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  716 672 276 180 133  
Balance sheet change%  -2.0% -6.1% -58.9% -34.8% -25.8%  
Added value  254.6 113.6 -59.5 -42.1 -34.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  55 -14 -62 -62 -62  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 -1.0 -2.0 -3.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  32.1% 12.7% -32.0% -305.7% -276.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  38.8% 12.6% -19.1% -32.2% -41.7%  
ROI %  67.8% 19.4% -27.8% -39.2% -55.8%  
ROE %  52.5% 15.3% -26.2% -39.3% -56.7%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  64.7% 62.5% 80.8% 83.3% 62.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -182.4% -281.5% 221.4% 189.3% 243.6%  
Gearing %  0.0% 0.1% 0.3% 0.3% 0.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 620.0% 430.4% 54.8% 201.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.9 2.2 3.5 3.9 2.1  
Current Ratio  2.9 2.2 3.5 3.9 2.1  
Cash and cash equivalent  464.4 320.0 132.5 80.1 84.3  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  384.0 290.3 130.3 88.2 53.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  127 57 -30 0 -34  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  127 57 -30 0 -34  
EBIT / employee  125 44 -45 0 -65  
Net earnings / employee  108 34 -42 0 -66